Olema Pharmaceuticals, Inc.Employee Arbitration Agreement • September 21st, 2020 • Olema Pharmaceuticals, Inc. • Pharmaceutical preparations • California
You are currently employed by Olema Pharmaceuticals, Inc. (the “Company”) as its Chief Scientific Officer. The terms and conditions in this letter (the “Agreement”) will become effective as of the date above, and will supersede and replace the terms and conditions set forth in your offer letter from the Company dated March 20, 2007 (the “Original Offer Letter”).
CLINICAL COLLABORATION AND SUPPLY AGREEMENTClinical Collaboration and Supply Agreement • September 21st, 2020 • Olema Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Clinical Collaboration and Supply Agreement (the “Agreement”) is made and entered into effective as of July 22, 2020 (the “Effective Date”) by and between Olema Pharmaceuticals, Inc., a Delaware corporation, having a place of business at 665 3rd St, San Francisco, CA 94107 (“Olema”), and Novartis Institutes for BioMedical Research, Inc., a Delaware corporation, having a place of business at 181 Massachusetts Avenue, Cambridge, MA 02139 (“Novartis”). Olema and Novartis are sometimes individually referred to in this Agreement as a “Party” and collectively as the “Parties.”
September 1, 2020 Mr. Sean Bohen VIA EMAIL Re: Offer of Employment Dear Sean:Olema Pharmaceuticals, Inc. • September 21st, 2020 • Pharmaceutical preparations
Olema Pharmaceuticals, Inc. (the “Company”) is pleased to offer you employment as the Company’s Chief Executive Officer (“CEO”) on the terms and conditions set forth in this letter agreement (the “Agreement”).
